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Sir,
Paraneoplastic pemphigus (PNP) is an autoimmune blis-
tering disorder characterized by severe mucosal erosions 
and polymorphous skin eruptions in association with 
underlying neoplasia (1). Most cases of PNP are asso-
ciated with haematological malignancy; however, solid 
non-haematological neoplasms have also been described 
in PNP comprising epithelial-origin carcinoma and me-
senchymal-origin sarcoma (1, 2). The association of PNP 
and soft tissue sarcoma is rare; to date approximately 14 
cases have been reported (2–5). Of the reported sarcoma 
cases there have been 4 cases of follicular dendritic cell 
sarcoma (FDCS) (3). The prognosis of PNP is very poor 
and may not parallel the treatment of the tumour (1); 
however, PNP cases associated with benign tumours, 
such as thymomas and Castleman’s tumours, generally 
showed decreased antibody titre and great improvement 
of clinical signs following tumour resection (2, 6).
CASE REPORT
A 67-year-old man visited our department with a 4-month 
history of painful ulcerations on the lips and oral mucosa. The 
patient also had conjunctival erosions in both eyes, but other 
parts of the body were not affected. Eight months earlier, during 
a routine examination, an incidental mass in the small bowel 
mesentery was found by abdominal computer tomography (CT) 
and he underwent complete resection of the mass 4 months later. 
The tumour was a well-demarcated white-gray-coloured lobula-
ted mass microscopically composed of spindle-shaped cells and 
dense lymphocytic infiltration with a lesser number of plasma 
cells and eosinophils (Fig. 1a). The spindle cells were reactive 
for CD35, smooth muscle actin, leukocyte common antigen, 
S-100, anaplastic lymphoma kinase and TdT, but negative for 
CD21, c-kit, CD34, CD31, desmin, epithelial membrane anti-
gen, CD68 and cytokeratin. The infiltrating lymphocytes stain-
ed with Ki-67, CD3, CD20 and CD30. Oral and conjunctival 
blisters were first observed several days after tumour resection, 
and one month after surgery progressive ptosis and dysphagia 
also developed. He was diagnosed with myasthenia gravis (MG). 
Thymoma was ruled out based on a chest CT scan. Treatment 
with prednisolone, azathioprine and pyridostigmine bromide 
was initiated, but during the course of treatment, the oral lesions 
worsened and he was referred to our hospital. Physical exami-
nation revealed extensive erosions and ulcerations of the buccal 
mucosa, tongue and lips (Fig. 1b). Conjunctival erosions and 
scarring were shown, but, no skin lesions were noted. Biopsy 
from the buccal aspect of the lower lip and conjunctiva revealed 
vacuolization of basal cells with suprabasilar acantholytic cleft 
(Fig. 1c, d). Direct immunofluorescence (IF) revealed weak 
deposition of IgG and C3 at the basement membrane zone. 
Indirect IF showed a typical circulating IgG that bound to the 
Paraneoplastic Pemphigus Developed Shortly after Resection of Follicular Dendritic Cell Sarcoma
Sang Eun Lee1, Hae Ryoung Kim2, Takashi Hashimoto3 and Soo-Chan Kim1*
1Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Yongdong Severance Hospital, 146-92, 
Dogok-dong, Kangnam-gu, 2Department of Pathology, Seoul National University Bundang Hospital Seoul, Korea, and 3Department of Dermatology  
Kurume University School of Medicine, Fukuoka, Japan. *E-mail: kimsc@yumc.yonsei.ac.kr
Accepted December 12, 2007.
Fig. 1. (a) Histopathological features 
of the tumour show proliferation of 
spindle cells in a myxoid stroma and 
dense inflammatory cells, mainly 
lymphocytes and a few plasma 
cells (haematoxylin and eosin; 
H&E × 200). (b) Ulcerations and 
hemorrhagic crusts on the oral mucosa 
and both lips. (c) Biopsy from oral 
lesions shows vacuolization of basal 
cells with suprabasilar acantholytic 
cleft (H&E × 200). (d) Acantholysis 
of the basal layer in the form of a “row 
of tombstones” in the epidermis of 
conjunctival lesions (H&E × 200).
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surface of keratinocytes at a titre of 1:160 on normal human 
skin. Desmoglein (Dsg) enzyme-linked immunoassay (ELISA) 
showed negative results for Dsg1 and Dsg3. Immunoblotting 
analysis using normal human epidermal extracts detected the 
210-kDa envoplakin and 190-kDa periplakin, confirming the 
diagnosis of PNP (Fig. 2). Oral prednisolone, 40 mg daily and 
cyclosporine, 200 mg daily and intravenous immunoglobulin 
2 g/kg daily for 5 days resulted in an improvement in the oral 
and conjunctival mucosal lesions. The symptoms of MG also 
improved, and follow-up examination for acetylcholine receptor 
binding antibody showed a serum level elevated by 7.276 nmol/l 
and the acetylcholine receptor blocking antibody was positive 
by 38.5%. At one year after tumour resection, multiple liver 
metastasis were found during follow-up. The haematoxylin and 
eosin histological features of the metastatic tumour were similar 
to those of the primary tumour, with spindle-shaped cells with 
dense lymphocytic infiltration, but the immunohistochemical 
findings were CD35- and CD21-positive. Several pathologists 
confirmed these immunohistochemical findings and concluded 
that the final diagnosis of the tumour was FDCS.
DISCUSSION
The patient developed oral and conjunctival ulcerations 
and MG shortly after the associated tumour resection, 
and the lesions were exclusively limited to the mucous 
membranes without skin involvement. In addition, 
Dsg ELISA showed negative results for both Dsg1 and 
Dsg3. However, our patient demonstrated antibodies 
against 210-kDa envoplakin and 190-kDa periplakin on 
immunoblotting. According to the modified version of 
the diagnostic criteria suggested by Camisa & Helm (7), 
our patient fulfils three major criteria, the polymorphous 
mucocutaneous eruption, concurrent internal neoplasia, 
and the immunoblotting results that detected both 210-
kDa envoplakin and 190-kDa periplakin, which are the 
most characterized and consistently recognized antibo-
dies of PNP, confirming the diagnosis of PNP.
The most unusual clinical feature of our patient is 
development of mucosal and conjunctival erosions and 
MG shortly after the tumour resection. Wang et al. (8) de-
monstrated that B-cells in Castleman’s tumour produced 
autoantibodies against the plakin family and Dsg3 in a 
patient with PNP, and recently other tumours associated 
with PNP such as thymomas and FDCS were also repor-
ted to have B-cell clones producing autoantibodies (3). 
Therefore, it may be possible that the operation itself trig-
gered the antibody production from the B-cells of FDCS 
or haematogenous spread of antibody-producing tumour 
cells in our patient. If this hypothesis is true, extremely 
careful resection is necessary to prevent stimulation or 
dissemination of antibody-producing tumour cells. 
Another unusual clinical finding in our case was that 
the lesions were limited exclusively to the oral and con-
junctival mucosa without skin involvement. Although 
the oral mucosa is involved in all cases of PNP, it is very 
rare for the lesions to be limited to the mucosa (2). To 
our knowledge there have been two reported cases that 
showed limited mucosal involvement (9, 10).
Amagai et al. (11) suggested that most patients with 
PNP have Dsg3 autoantibodies and that the antibody 
plays a pathogenic role in PNP. However, in our patient, 
the mucosal lesions showed suprabasal acantholysis 
similar to pemphigus vulgaris, but the Dsg ELISA was 
negative for Dsg3. One possible explanation for this 
unusual feature is that the titre of anti-Dsg3 antibo-
dies in our patient may be too low to be detected by 
ELISA. Another possibility is that the acantholysis 
in our patient may have been induced by antibodies 
against epithelial proteins other than Dsg3. Several case 
reports have shown PNP patients with negative results 
in Dsg ELISA (12, 13). In spite of the absence of anti-
Dsg3 IgG, patients showed clinical manifestations of 
PNP. In addition to the PNP antigenic complex, other 
target epithelial antigens and their specific roles in the 
pathophysiological mechanisms of PNP remain to be 
discovered. 
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